Literature DB >> 32172819

Thrombocytopenia-Associated Multiple Organ Failure.

Trung C Nguyen1.   

Abstract

Thrombocytopenia-associated multiple organ failure is a clinical phenotype encompassing a spectrum of syndromes associated with disseminated microvascular thromboses. Autopsies performed in patients that died with thrombotic thrombocytopenic purpura, hemolytic uremic syndrome, or disseminated intravascular coagulation reveal specific findings that can differentiate these 3 entities. Significant advancements have been made in our understanding of the pathologic mechanisms of these syndromes. Von Willebrand factor and ADAMTS-13 play a central role in thrombotic thrombocytopenic purpura. Shiga toxins and the complement pathway drive the hemolytic uremic syndrome pathology. Tissue factor activity is vital in the development of disseminated intravascular coagulation.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DIC; HUS; Plasma exchange; Platelet; Shiga toxin; TAMOF; TTP; Thrombocytopenia

Mesh:

Year:  2020        PMID: 32172819     DOI: 10.1016/j.ccc.2019.12.010

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  2 in total

1.  Thrombotic microangiopathies in Pediatrics: current nomenclature and differential diagnoses with Thrombocytopenia-associated multiple organ failure (TAMOF).

Authors:  João Paulo Silva Cezar; Selma Harue Kawahara; Frederico Ribeiro Pires
Journal:  Rev Paul Pediatr       Date:  2021-12-20

2.  Development and validation of a prediction model for in-hospital mortality of patients with severe thrombocytopenia.

Authors:  Yan Lu; Qiaohong Zhang; Jinwen Jiang
Journal:  Sci Rep       Date:  2022-04-15       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.